VOR
Vor Biopharma Inc.
NASDAQ · USHealthcareBiotechnology
$17.45-3.54%
Price as of Jul 20, 2026
VOR growth
Vor Biopharma Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- +482.8%
- EBIT
- —
- EPS
- —
- Free cash flow
- -49.7%
- Operating cash flow
- -49.5%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +99.6%
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -43.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.